EDISON, NJ
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)BIOCON INC, founded in 1998, is a community nonprofit in the Health Care sector that reported $4.6M in total revenue in fiscal year 2024. Revenue surged 21% from the prior year, signaling strong growth momentum. Expenses of $4.1M left a modest 11% surplus.
BIOCON, INC'S. (BIO) MISSION IS TO SUPPORT THE TAX-EXEMPT MISSION OF THE MUSCULOSKELETAL TRANSPLANT FOUNDATION INC., (MTF). BIOCON, INC. (BIO) WAS FORMED TO SERVE AS THE SOLE VOTING MEMBER OF, AND ACT AS THE HOLDING COMPANY FOR, THE MUSCULOSKELETAL TRANSPLANT FOUNDATION INC., (MTF) A NON-PROFIT 501(C) ORGANIZATION AND DEUTSCHES INSTITUT FUR ZELL-UND GEWEBEERSATZ GMBH, (DIZG) A GERMAN NON-PROFIT ORGANIZATION (AS DISCLOSED ON FORM 5471). MTF'S MISSION IS TO PROVIDE QUALITY ALLOGRAFT TISSUES FOR TRANSPLANTATION, RESEARCH AND EDUCATION. DIZG SPECIALIZES IN CULTURING AND DISTRIBUTION OF KERATINOCYTES, MUSCULOSKELETAL, AND OTHER TISSUE FORMS. BIO, AS HOLDING COMPANY, HAS AUTHORITY TO APPROVE FUNDAMENTAL AMENDMENTS TO ORGANIZATIONAL DOCUMENTS AND TO APPROVE CERTAIN CORPORATE TRANSACTIONS SUCH AS MERGERS AND DISSOLUTIONS. BIO ALSO HAS THE EXCLUSIVE RIGHT TO ELECT OR APPOINT ALL MEMBERS OF THE BOARD OF DIRECTORS OF MTF AND DIZG. BIO CONTINUES TO MONITOR AND GUIDE THE ACTIVITIES OF MTF AND DIZG, AS WELL AS ANY AFFILIATES THAT MAY BE FORMED OR ACQUIRED IN THE FUTURE, TO FOSTER THE PROVISION OF HIGH QUALITY HUMAN ALLOGRAFT TISSUE TO THE COMMUNITY THROUGH THE MOST ECONOMICAL AND EFFICIENT SYSTEM POSSIBLE.
BIO PROGRAM SERVICE ACTIVITY: BIO'S PROGRAM SERVICE ACTIVITY IS TO SUPPORT THE TAX-EXEMPT MISSION OF MTF AND DIZG. BIO'S SUPPORT OF MTF INCLUDES THE SEGREGATION, PROTECTION AND OPERATION OF REAL...
BIO PROGRAM SERVICE ACTIVITY: BIO'S PROGRAM SERVICE ACTIVITY IS TO SUPPORT THE TAX-EXEMPT MISSION OF MTF AND DIZG. BIO'S SUPPORT OF MTF INCLUDES THE SEGREGATION, PROTECTION AND OPERATION OF REAL PROPERTY ASSETS USED BY MTF IN CARRYING OUT ITS CHARITABLE ACTIVITIES. BIO HOLDS REAL ESTATE VIA ITS FOUR DISREGARDED ENTITIES (AS DISCLOSED ON SCHEDULE R, PART 1). AS SOLE MEMBER OF DIZG, BIO PROVIDES GUIDANCE TO FURTHER EXPAND GLOBAL REACH TO PATIENTS AROUND THE WORLD. FOR INDIVIDUAL STORIES ABOUT DONOR FAMILIES, PLEASE VISIT MTF'S WEBSITE AT HTTPS://WWW.MTFBIOLOGICS.ORG/WHO-WE-SERVE/DONORS-COMMUNITY/DONORS-FAMILI ES. STORIES ABOUT RECIPIENTS ARE ALSO AVAILABLE ON THE WEBSITE AT HTTPS://WWW.MTFBIOLOGICS.ORG/WHO-WE-SERVE/DONORS-COMMUNITY/RECIPIENTS.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2024 | 2023 | Change | |
|---|---|---|---|
| Revenue | $4,649,455 | $3,848,762 | +0.2% |
| Expenses | $4,130,474 | $3,196,702 | +0.3% |
| Net Income | $518,981 | $652,060 | -0.2% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| WILLIAM W TOMFORD MD | DIRECTOR | 0.00 |
Director
|
$0 | $0 | $75,000 |
| DONALD HACKBARTH MD | DIRECTOR | 0.00 |
Director
|
$0 | $0 | $35,000 |
| JOSEPH D ZUCKERMAN MD | DIRECTOR | 0.00 |
Director
|
$0 | $0 | $30,000 |
| SYMERIA T HUDSON | DIRECTOR | 0.00 |
Director
|
$0 | $0 | $0 |
| JOSEPH A BUCKWALTER MD | DIRECTOR | 0.00 |
Director
|
$0 | $0 | $27,500 |
| SHARON GABRIELSON | DIRECTOR | 0.00 |
Director
|
$0 | $0 | $25,000 |
| ALLAN GROSS MD | NON-VOTING DIRECTOR | 0.00 |
Director
|
$0 | $0 | $0 |
| GERALD FINERMAN MD | NON-VOTING DIRECTOR | 0.00 |
Director
|
$0 | $0 | $0 |
| JOSEPH A YACCARINO | PRESIDENT / CEO | 0.00 |
Officer
|
$0 | $56,874 | $958,758 |
| MICHAEL J KAWAS | TREASURER / CFO | 0.00 |
Officer
|
$0 | $36,365 | $697,388 |
| JENNIFER BIRMINGHAM | SECRETARY / GENERAL COUNSEL | 0.00 |
Officer
|
$0 | $56,656 | $533,939 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2024 | $4,649,455 | $4,130,474 | $30,182,299 | $518,981 |
| 2023 | $3,848,762 | $3,196,702 | $30,050,664 | $652,060 |
| 2022 | $3,214,643 | $2,370,753 | $16,971,976 | $843,890 |
| 2021 | $3,342,644 | $2,564,076 | $16,726,556 | $778,568 |
| 2020 | $3,223,664 | $2,433,895 | $16,802,691 | $789,769 |
| 2019 | $3,431,997 | $2,699,107 | $16,108,259 | $732,890 |
| 2018 | $3,469,939 | $3,161,133 | $18,191,937 | $308,806 |
Compare BIOCON INC with other nonprofits in New Jersey and across the country.